1. Subjects who give written informed consent to participate in the study.2. Subjects aged between 19-59 and 60-80 years.3. Body mass index between 18 and 29.9 kg / m2.4. Women of childbearing potential using safe contraceptive methods during the study.5. General, regional and apparatus physical examination: normal or without clinically significant alterations.6. Clinical Laboratory testing within the range of reference values, or outside ??but not clinically significant (Only for Phase I)

1. Subjects who give written informed consent to participate in the study.2. Subjects aged between 19-59 and 60-80 years.3. Body mass index between 18 and 29.9 kg / m2.4. Women of childbearing potential using safe contraceptive methods during the study.5. General, regional and apparatus physical examination: normal or without clinically significant alterations.6. Clinical Laboratory testing within the range of reference values, or outside ??but not clinically significant (Only for Phase I)

1. Subjects who give written informed consent to participate in the study. 2. Subjects aged between 19-59 and 60-80 years. 3. Body mass index between 18 and 29.9 kg / m2. 4. Women of childbearing potential using safe contraceptive methods during the study. 5. General, regional and apparatus physical examination: normal or without clinically significant alterations. 6. Clinical Laboratory testing within the range of reference values, or outside but not clinically significant (Only for Phase I)

1. Subjects who give written informed consent to participate in the study. 2. Subjects aged between 19-59 and 60-80 years. 3. Body mass index between 18 and 29.9 kg / m2. 4. Women of childbearing potential using safe contraceptive methods during the study. 5. General, regional and apparatus physical examination: normal or without clinically significant alterations. 6. Clinical Laboratory testing within the range of reference values, or outside but not clinically significant (Only for Phase I)